Get started
Author

Tim Flaadt

Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial
2023 · Tim Flaadt, Ruth L. Ladenstein, et al. · Journal of Clinical Oncology · 62
PDF
Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study
2024 · Pauline Hägele, Paulina Staus, et al. · The Lancet Haematology · 22
PDF
Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients
2024 · Linus D. Kloker, Mirjana Sidiras, et al. · Lung Cancer · 22
PDF
Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment
2021 · Christian Martin Seitz, Tim Flaadt, et al. · Frontiers in Immunology · 21
PDF
NUT Carcinoma in Children and Adolescents: The Expert European Standard Clinical Practice Harmonized Recommendations
2022 · Lauriane Lemelle, Tim Flaadt, et al. · Journal of Pediatric Hematology/Oncology · 20
Primary lung carcinoma in children and adolescents – Clinical characteristics and outcome of 12 cases from the German registry for rare paediatric tumours (STEP)
2021 · Sarah Voggel, Michael Abele, et al. · Lung Cancer · 15
Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3
2024 · Thomas Eichholz, Florian Heubach, et al. · Cancer Immunology Immunotherapy · 14
PDF
Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort Study
2025 · Tim Flaadt, Jonas Rehm, et al. · Cancers · 13
PDF
NUT carcinoma in pediatric patients: Characteristics, therapeutic regimens, and outcomes of 11 cases registered with the German Registry for Rare Pediatric Tumors (STEP)
2023 · Tim Flaadt, Hannah Wild, et al. · Pediatric Blood & Cancer · 9
PDF
Rare and potentially fatal ‐ Cytogenetically cryptic TNIP1::PDGFRB and PCM1::FGFR1 fusion leading to myeloid/lymphoid neoplasms with eosinophilia in children
2023 · Ann-Cathrine Berking, Tim Flaadt, et al. · Cancer Genetics · 9
Current treatment strategies for first relapse of high-risk neuroblastoma
2026 · Sveva Castelli, Franziska Schulze, et al. · European Journal of Cancer · 8
Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse
2023 · Tim Flaadt, Martin Ebinger, et al. · Journal of Clinical Medicine · 8
PDF
Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies
2021 · Magdalena M. Brune, Achim Rau, et al. · Cancers · 7
PDF
NUT carcinoma in children and adolescents: An analysis of the European Cooperative Study Group on pediatric rare tumors (EXPeRT)
2025 · Tim Flaadt, Lauriane Lemelle, et al. · Lung Cancer · 5
PDF
Local MRI before and after Tumor Resection in Neuroblastoma: Impact of Residual Disease on Event Free Survival
2023 · Jürgen F. Schäfer, Sebastian Gassenmaier, et al. · Journal of Clinical Medicine · 5
PDF
Haploidentical hematopoietic stem cell transplantation as individual treatment option in pediatric patients with very high-risk sarcomas
2023 · Thomas Eichholz, Michaela Döring, et al. · Frontiers in Oncology · 5
PDF
123Iodine-metaiodobenzylguanidine scintigraphy versus whole-body magnetic resonance imaging with diffusion-weighted imaging in children with high-risk neuroblastoma — pilot study
2021 · Sebastian Gassenmaier, Roland Bares, et al. · Pediatric Radiology · 5
Antiemetic prophylaxis with fosaprepitant and granisetron in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
2020 · Karin Melanie Cabanillas Stanchi, Julia Vek, et al. · Journal of Cancer Research and Clinical Oncology · 5
PDF
Abstract A013: Haploidentical stem cell transplantation and subsequent immunotherapy with antiGD2 antibody for patients with relapsed metastatic neuroblastoma
2019 · Peter Lang, Tim Flaadt, et al. · Cancer Immunology Research · 5
Antiemetic Prophylaxis with Fosaprepitant and 5-HT3-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
2020 · Karin Melanie Cabanillas Stanchi, Semjon Willier, et al. · Drug Design Development and Therapy · 3
PDF
Combined Metabolic and Functional Tumor Volumes on [18F]FDG-PET/MRI in Neuroblastoma Using Voxel-Wise Analysis
2023 · Maryanna Chaika, Simon Männlin, et al. · Journal of Clinical Medicine · 2
PDF
Clinical management of metachromatic leukodystrophy cases identified in the German and Austrian Newborn screening pilots
2026 · Lucia Laugwitz, Pascal Martin, et al. · Orphanet Journal of Rare Diseases · 1
PDF
Additional file 1 of Clinical management of metachromatic leukodystrophy cases identified in the German and Austrian Newborn screening pilots
2026 · Lucia Laugwitz, Pascal Martin, et al. · Figshare
Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation
2026 · Carmen Junk, Sebastian Michaelis, et al. · Pediatric Blood & Cancer
PDF
Neuroblastom
2026 · Sveva Castelli, Tim Flaadt, et al. · Die Onkologie
PDF
Works count: 33
Citation count: 266
H-index: 9
I10-index: 8
Year
Topic
Type